S
Sharla Chenoweth
Researcher at Medtronic plc
Publications - 8
Citations - 3735
Sharla Chenoweth is an academic researcher from Medtronic plc. The author has contributed to research in topics: Valve replacement & Aortic valve replacement. The author has an hindex of 8, co-authored 8 publications receiving 3271 citations.
Papers
More filters
Journal ArticleDOI
Transcatheter Aortic Valve Replacement with a Self-Expanding Prosthesis
David H. Adams,Jeffrey J. Popma,Michael J. Reardon,Steven J. Yakubov,Joseph S. Coselli,G. Michael Deeb,Thomas G. Gleason,Maurice Buchbinder,James B. Hermiller,Neal S. Kleiman,Stan Chetcuti,John Heiser,William Merhi,George L. Zorn,Peter Tadros,Newell Robinson,George Petrossian,G. Chad Hughes,J. Kevin Harrison,John V. Conte,Brijeshwar Maini,Mubashir Mumtaz,Sharla Chenoweth,Jae K. Oh +23 more
TL;DR: In patients with severe aortic stenosis who are at increased surgical risk, TAVR with a self-expanding transcatheter aorti-valve bioprosthesis was associated with a significantly higher rate of survival at 1 year than surgical aorticsvalve replacement.
Journal ArticleDOI
Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery.
Jeffrey J. Popma,David H. Adams,Michael J. Reardon,Steven J. Yakubov,Neal S. Kleiman,David Heimansohn,James B. Hermiller,G. Chad Hughes,J. Kevin Harrison,Joseph S. Coselli,Jose G Diez,Ali Kafi,Theodore Schreiber,Thomas G. Gleason,John V. Conte,Maurice Buchbinder,G. Michael Deeb,Blase A. Carabello,Patrick W. Serruys,Sharla Chenoweth,Jae K. Oh +20 more
TL;DR: TAVR with a self-expanding bioprosthesis was safe and effective in patients with symptomatic severe aortic stenosis at prohibitive risk for surgical valve replacement.
Journal ArticleDOI
Early Experience With New Transcatheter Mitral Valve Replacement
Vinayak Bapat,Vivek Rajagopal,Christopher Meduri,R. Saeid Farivar,Antony Walton,Stephen J. Duffy,Robert Gooley,Aubrey Almeida,Michael J. Reardon,Neal S. Kleiman,Konstantinos Spargias,Stratis Pattakos,Martin K.C. Ng,Michael K. Wilson,David H. Adams,Martin B. Leon,Michael J. Mack,Sharla Chenoweth,Paul Sorajja,Intrepid Global Pilot Study Investigators +19 more
TL;DR: TMVR with the valve was feasible in a study group at high or extreme risk for conventional mitral valve replacement, and these results inform trial design of TMVR in lower-risk patients with severe mitral valves regurgitation.
Journal ArticleDOI
Self-expanding transcatheter aortic valve replacement using alternative access sites in symptomatic patients with severe aortic stenosis deemed extreme risk of surgery
Michael J. Reardon,David H. Adams,Joseph S. Coselli,G. Michael Deeb,Neal S. Kleiman,Stan Chetcuti,Steven J. Yakubov,David Heimansohn,James B. Hermiller,G. Chad Hughes,J. Kevin Harrison,Kamal R. Khabbaz,Peter Tadros,George L. Zorn,William Merhi,John Heiser,George Petrossian,Newell Robinson,Brijeshwar Maini,Mubashir Mumtaz,Joon S. Lee,Thomas G. Gleason,Jon R. Resar,John V. Conte,Daniel R. Watson,Sharla Chenoweth,Jeffrey J. Popma +26 more
TL;DR: These data demonstrate that the CoreValve transcatheter heart valve delivered by an alternative access provides a suitable alternative for treatment of extreme risk patients with symptomatic severe aortic stenosis, who have prohibitive iliofemoral anatomy and no surgical options.
Journal ArticleDOI
Outcomes for the Commercial Use of Self-Expanding Prostheses in Transcatheter Aortic Valve Replacement: A Report From the STS/ACC TVT Registry
Paul Sorajja,Susheel Kodali,Michael J. Reardon,Wilson Y. Szeto,Stanley Chetcuti,James B. Hermiller,Sharla Chenoweth,David H. Adams,Jeffrey J. Popma +8 more
TL;DR: Commercial adoption of the Evolut R platform is associated with significant improvements in acute outcomes for patients undergoing TAVR for aortic stenosis, as compared with patients treated with the CoreValve device.